Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: AbbVie
Relapsed/Refractory Multiple Myeloma
United States, Australia, Germany, Italy, Japan +2 more
Sponsor: Verastem, Inc.
Low Grade Serous Ovarian Cancer
United States, Australia, Belgium, Canada, Denmark +11 more
Sponsor: Pfizer
COVID-19 SARS-CoV-2 Infection
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
Sponsor: Insmed Incorporated
Pulmonary Hypertension · Interstitial Lung Disease
United States, Argentina, Australia, Austria, Belgium +22 more
Sponsor: Pfizer
Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: UCB Biopharma SRL
Atopic Dermatitis
United States, Bulgaria, Canada, Czechia, Germany +4 more
- An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia GravisEnrolling By Invitation
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
Italy, Japan, Poland, Taiwan, Turkey (Türkiye)
- Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative TreatmentActive Not Recruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Australia, Austria, Brazil, Canada +19 more
- A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic DermatitisActive Not Recruiting
Sponsor: AbbVie
Atopic Dermatitis
United States, Japan, South Korea, United Kingdom
Sponsor: AstraZeneca
Newly Diagnosed Multiple Myeloma
United States, Australia, Brazil, Canada, Denmark +10 more
Sponsor: UCB Biopharma SRL
Axial Spondyloarthritis · Ankylosing Spondylitis · r-axSpa · Nr-axSpa
United States, Belgium, Bulgaria, China, Czechia +9 more
Sponsor: AbbVie
Solid Tumors Harboring MET Amplification
United States, Israel, Japan, South Korea, Spain
Sponsor: ViiV Healthcare
HIV Infections
United States, Argentina, Australia, Canada, Japan +4 more
- A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia GravisActive Not Recruiting
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
Italy, Japan, Poland, Turkey (Türkiye)
Sponsor: Novo Nordisk A/S
Overweight and Obesity
Japan, South Korea
Sponsor: Takeda
Kidney Disease
United States, Argentina, Australia, Austria, Canada +21 more
Sponsor: AbbVie
Juvenile Idiopathic Arthritis
United States, Argentina, Australia, Austria, Brazil +12 more
- A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Recruiting
Sponsor: Merck Sharp & Dohme LLC
B-cell Acute Lymphoblastic Leukemia
Denmark, Greece, Israel, Italy, Japan +2 more
Sponsor: Merck Sharp & Dohme LLC
Advanced Solid Neoplasms
United States, Argentina, Australia, Canada, Colombia +16 more
Sponsor: AbbVie
Multiple Myeloma
United States, China, Israel, Japan
Sponsor: Mirati Therapeutics Inc.
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +30 more
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesActive Not Recruiting
Sponsor: Eli Lilly and Company
Obesity · Overweight · Overweight or Obesity
United States, Brazil, China, India, Japan +5 more
Sponsor: AbbVie
Non-Small Cell Lung Cancer
United States, Brazil, China, Israel, Japan +2 more
- A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)Active Not Recruiting
Sponsor: UCB Biopharma SRL
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
United States, Australia, Belgium, Brazil, Czechia +15 more
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +35 more